Latest Cancer News

Interim Results of X-396 in ALK positive Non-Small Cell Lung Cancer Appear Promising (08-29-2014)
Preliminary results from a small phase 1 study of X-396, a novel anaplastic lymphoma kinase (ALK) inhibitor showed that X-396 is well tolerated and has antitumor activity in patients with ALK positive... Continue Reading

Risk of Breast Cancer Recurrence Doesn’t Increase with TNF Inhibitor Use (08-28-2014)
According to the results of a recently published study from Swedish investigators treatment with tumor necrosis factor inhibitors (TNF) does not appear to increase the rate of breast cancer recurrence... Continue Reading

Advaxis and Merck Form Collaboration to Evaluate Investigational Combination of Two Novel Immunotherapy Candidates for Advanced Prostate Cancer (08-27-2014)
Advaxis, Inc.a clinical-stage biotechnology company developing cancer immunotherapies, has entered into a clinical trial collaboration agreement with Merck to evaluate the safety and efficacy of ADXS-PSA... Continue Reading

More Cancer News

Locations

Scarborough Office
100 Campus Drive, Suite 108
Scarborough, Maine 04074-9308
(207) 396-7600
Fax (207) 396-7610
Brunswick Office
81 Medical Center Drive
Suite 1300G
Brunswick, ME 04011
(207) 729-1148
Fax (207)729-2789
Biddeford Office
26 West Cole Road
Biddeford, Maine 04005-9407
(207) 282-0448
Fax (207)286-9126
Sanford Office
27 Industrial Avenue
Sanford, ME 04073
(207)490-7777
Fax (207) 490-7779